Striving for decreased post-transplant hepatocellular carcinoma recurrence without excluding potentially curable patients: the utility of tumor biology. Editorial Article uri icon

Overview

publication date

  • October 1, 2019

Identity

PubMed Central ID

  • PMC6791992

Scopus Document Identifier

  • 80051910504

Digital Object Identifier (DOI)

  • 10.1016/j.jhep.2010.12.040

PubMed ID

  • 31673552

Additional Document Info

volume

  • 8

issue

  • 5